{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:32:06Z","timestamp":1789810326155,"version":"4.0.1"},"reference-count":62,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT103212MF"],"award-info":[{"award-number":["WT103212MF"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["573642\/2008-7"],"award-info":[{"award-number":["573642\/2008-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["443586\/2014-4"],"award-info":[{"award-number":["443586\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["300699\/2013-1"],"award-info":[{"award-number":["300699\/2013-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e4o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/102.835\/2012"],"award-info":[{"award-number":["E-26\/102.835\/2012"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e4o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["210.918\/2015"],"award-info":[{"award-number":["210.918\/2015"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.00535","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:05:19Z","timestamp":1490659519000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":81,"title":["The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans"],"prefix":"10.3389","volume":"8","author":[{"given":"Luna S.","family":"Joffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charley C.","family":"Staats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia","family":"Kmetzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Schrank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilene H.","family":"Vainstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio L.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.2174\/1568026616666160506130226","article-title":"Antimicrobial activities of 1-H-benzimidazole-based molecules.","volume":"16","author":"Ates-Alagoz","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-14-2681","article-title":"Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model.","volume":"21","author":"Bai","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1016\/j.bmc.2012.09.013","article-title":"The therapeutic journey of benzimidazoles: a review.","volume":"20","author":"Bansal","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"290","key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00290","article-title":"Virulence of Cryptococcus sp. biofilms in vitro and in vivo using Galleria mellonella as an alternative model.","volume":"7","author":"Benaducci","year":"2016","journal-title":"Front. Microbiol."},{"key":"B6","first-page":"221","article-title":"Rapid methods to extract DNA and RNA from Cryptococcus neoformans.","volume":"1","author":"Bolano","year":"2001","journal-title":"FEMS Yeast Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2016_7","article-title":"Fungal biofilms: update on resistance.","volume":"931","author":"Borghi","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","article-title":"Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.","volume":"42","author":"Casadevall","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0022-1759(92)90209-C","article-title":"Monoclonal antibody based ELISAs for cryptococcal polysaccharide.","volume":"154","author":"Casadevall","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"B10","doi-asserted-by":"publisher","first-page":"D363","DOI":"10.1093\/nar\/gkj123","article-title":"OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups.","volume":"34","author":"Chen","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"B11","author":"ClinicalTrials.gov","year":"2013","journal-title":"Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis (ASTRO-CM)."},{"key":"B12","author":"ClinicalTrials.gov","year":"2016","journal-title":"A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1590\/0001-3765201520140704","article-title":"Fungal colonization of the brain: anatomopathological aspects of neurological cryptococcosis.","volume":"87","author":"Colombo","year":"2015","journal-title":"An. Acad. Bras. Cienc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1128\/AAC.38.2.378","article-title":"In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles.","volume":"38","author":"Cruz","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1128\/IAI.68.7.4225-4237.2000","article-title":"Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.","volume":"68","author":"Feldmesser","year":"2000","journal-title":"Infect. Immun."},{"key":"B16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4269\/ajtmh.1986.35.350","article-title":"Marrow aplasia during high dose mebendazole treatment.","volume":"35","author":"Fernandez-Banares","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2885.1984.tb00886.x","article-title":"Interaction of Fasciola hepatica with albendazole and its metabolites.","volume":"7","author":"Fetterer","year":"1984","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"D279","DOI":"10.1093\/nar\/gkv1344","article-title":"The Pfam protein families database: towards a more sustainable future.","volume":"44","author":"Finn","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","article-title":"Treatment of giardiasis.","volume":"14","author":"Gardner","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1128\/IAI.68.2.832-838.2000","article-title":"Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.","volume":"68","author":"Goldman","year":"2000","journal-title":"Infect. Immun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0169-4758(90)90228-V","article-title":"The metabolism of benzimidazole anthelmintics.","volume":"6","author":"Gottschall","year":"1990","journal-title":"Parasitol. Today"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/AAC.00048-11","article-title":"Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.","volume":"55","author":"Govender","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/tra.12233","article-title":"Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution.","volume":"16","author":"Hankins","year":"2015","journal-title":"Traffic"},{"key":"B24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1097-2765(01)00344-6","article-title":"Composition and functional characterization of yeast 66S ribosome assembly intermediates.","volume":"8","author":"Harnpicharnchai","year":"2001","journal-title":"Mol. Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1261\/rna.5255804","article-title":"Role of the yeast Rrp1 protein in the dynamics of pre-ribosome maturation.","volume":"10","author":"Horsey","year":"2004","journal-title":"RNA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/EC.00289-09","article-title":"A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans.","volume":"9","author":"Hu","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1128\/EC.3.2.420-429.2004","article-title":"Cryptococcus neoformans virulence gene discovery through insertional mutagenesis.","volume":"3","author":"Idnurm","year":"2004","journal-title":"Eukaryot. Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/clpt.2009.293","article-title":"Deconstructing the drug development process: the new face of innovation.","volume":"87","author":"Kaitin","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/clpt.2010.286","article-title":"Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009.","volume":"89","author":"Kaitin","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.fgb.2014.12.001","article-title":"Toward improved anti-cryptococcal drugs: novel molecules and repurposed drugs.","volume":"78","author":"Krysan","year":"2015","journal-title":"Fungal Genet. Biol."},{"issue":"a019760","key":"B31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.","volume":"4","author":"Kwon-Chung","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/03602539308993977","article-title":"Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants.","volume":"25","author":"Lanusse","year":"1993","journal-title":"Drug Metab. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1128\/IAI.73.10.6350-6362.2005","article-title":"Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy.","volume":"73","author":"Martinez","year":"2005","journal-title":"Infect. Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1128\/AAC.50.3.1021-1033.2006","article-title":"Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.","volume":"50","author":"Martinez","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1128\/AEM.02506-06","article-title":"Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light.","volume":"73","author":"Martinez","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MB-0006-2014","article-title":"Biofilm formation by Cryptococcus neoformans.","volume":"3","author":"Martinez","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2885.1990.tb00773.x","article-title":"The benzimidazole anthelmintic agents\u2013a review.","volume":"13","author":"McKellar","year":"1990","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/infdis\/172.4.1153","article-title":"A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT).","volume":"172","author":"Meshulam","year":"1995","journal-title":"J. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/jac\/dkv040","article-title":"Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England.","volume":"70","author":"Micallef","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.trstmh.2009.10.007","article-title":"Estimation of the cost of large-scale school deworming programmes with benzimidazoles.","volume":"104","author":"Montresor","year":"2010","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"e00647","key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00647-15","article-title":"Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids.","volume":"6","author":"Mor","year":"2015","journal-title":"mBio"},{"key":"B42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"B43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"issue":"52","key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-52","article-title":"Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.","volume":"15","author":"Ostermann","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS.","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"B46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-1-61779-228-1_16","article-title":"Identification of DNA sequences that flank a known region by inverse PCR.","volume":"772","author":"Pavlopoulos","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1128\/EC.00273-13","article-title":"Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.","volume":"13","author":"Rizzo","year":"2014","journal-title":"Eukaryot. Cell"},{"issue":"11717","key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/srep11717","article-title":"Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates.","volume":"5","author":"Rodrigues","year":"2015","journal-title":"Sci. Rep."},{"issue":"e0004429","key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004429","article-title":"Funding and innovation in diseases of neglected populations: the paradox of cryptococcal meningitis.","volume":"10","author":"Rodrigues","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/EC.00307-07","article-title":"Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan.","volume":"7","author":"Rodrigues","year":"2008","journal-title":"Eukaryot. Cell"},{"issue":"40920","key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2885.1988.tb00120.x","article-title":"The oxidative metabolism of fenbendazole: a comparative study.","volume":"11","author":"Short","year":"1988","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/QCO.0b013e32832fa214","article-title":"Treatment of cryptococcal meningitis in resource limited settings.","volume":"22","author":"Sloan","year":"2009","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing of the EECfAST","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"issue":"769851","key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/769851","article-title":"Exposure to mebendazole and pyrvinium during pregnancy: a Danish nationwide cohort study.","volume":"2012","author":"Torp-Pedersen","year":"2012","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"190","key":"B57","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8102.2","article-title":"Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection.","volume":"5","author":"Veljkovic","year":"2016","journal-title":"F1000Research"},{"key":"B58","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal interactions with the host immune system.","volume":"9","author":"Voelz","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","article-title":"Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: a mini-review.","volume":"97","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1091\/mbc.E06-08-0701","article-title":"A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis.","volume":"17","author":"Yoneda","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.00535\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T03:25:32Z","timestamp":1568949932000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.00535\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":62,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.00535","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]}}}